B-Cell Neoplasm — Trials

B-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 150 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07796373	Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 Inhibitor	not yet recruiting	Phase 2	32	National Heart, Lung, and Blood Institute (NHLBI)NIH	1	Sep 29, 2026	clinicaltrials
NCT07847957	Roginolisib Plus Obinutuzumab + Venetoclax in R/R CLL	not yet recruiting	Phase 1 / Phase 2	40	Dana-Farber Cancer InstituteOTHER	1	Sep 29, 2026